| Trial ID: | L6087 |
| Source ID: | NCT01602913
|
| Associated Drug: |
Pravastatin Alone
|
| Title: |
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Depression, Postpartum
|
| Interventions: |
DRUG: Pravastatin alone|DRUG: Paroxetine alone|DRUG: Pravastatin and paroxetine combined
|
| Outcome Measures: |
Primary: Incidence of T2DM defined as having at least 2 diagnostic codes indicating T2DM after the index date, or 1 diagnostic code and 1 prescription of oral anti-diabetic medications or insulin (or Byetta and Victoza) after the index date, Up to ten years |
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2011-12
|
| Completion Date: |
2012-05
|
| Results First Posted: |
|
| Last Update Posted: |
2014-07-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01602913
|
